90.6%
tirzepatidesemaglutideMounjaroWegovyThe BMJObesity
…Obesity drugs such as semaglutide (Wegovy) and tirzepatide (Mounjaro) produce substantial weight loss for patients but do …
8articles mentioning drugs
8drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Mounjaro ×
Mounjaro
This drug is selected. Its supporting articles are shown below.
Articles mentioning Mounjaro
8 articles · page 1 of 1tirzepatideMounjaroNHS
…The NHS spent £574m on tirzepatide (Mounjaro) last year, an almost fivefold annual increase and ar…
tirzepatideZepboundMounjarosemaglutideWegovyOzempicsteatohepatitisMASLDtype 2 diabetes mellitus (T2DM)metabolic dysfunction-associated steatotic liver disease (MASLD)
…ks.2 However, no real-world data exist investigating the use of tirzepatide in patients with type 2 diabetes mellitus (T2DM) and MASLD to u…
tirzepatidesemaglutideMounjaroWegovytype 2 diabetesobesityEli LillyGLP-1 agonist injectionsNovo Nordisk
… now in use—semaglutide (Wegovy), produced by Novo Nordisk, and tirzepatide (Mounjaro), produced by Eli Lilly—have been shown in clinical t…
Mounjaro: Experts issue warning over black market jabs, with fifth of areas still lacking NHS access
tirzepatideMounjaroThe BMJNHS
…local areas in England still do not provide the weight loss jab tirzepatide (Mounjaro) on the NHS six months after the drug was supposed to…
semaglutidetirzepatideZepboundOzempicMounjaroWegovyWorld Health OrganizationWHO
…on of glucagon-like peptide-1 receptor (GLP-1) agonists such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) needs to…
tirzepatideMounjaroThe BMJNHSweight-loss jab
…Less than half of England has access to tirzepatide (Mounjaro) through general practices, despite the NHS roll-out …
tirzepatideMounjaroPharmacies
…harmacies will be offered discounts on popular weight loss drug tirzepatide (Mounjaro) to take the sting out of next month’s planned price …